View in EDS

Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2.

Saved in:
Bibliographic Details
Title: Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2.
Authors: Stintzing S; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology (CCM), Berlin, Germany. Electronic address: sebastian.stintzing@charite.de., Tabernero J; Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Centro Cellex, Barcelona, Spain., Satoh T; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Dasari A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Lonardi S; Medical Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Eng C; Department of Medicine, Vanderbilt Ingram Cancer Center, Nashville, USA., Garcia-Carbonero R; Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Elez E; Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Centro Cellex, Barcelona, Spain., Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Sobrero AF; Department of Medical Oncology, Azienda Ospedaliera San Martino, Genoa, Italy., Yao JC; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Kasper S; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany., Arnold D; Department of Oncology and Hematology, Asklepios Tumorzentrum Hamburg, AK Altona, Hamburg, Germany., Basic E; Department of Business and Economics, Berlin School of Economics and Law, Berlin, Germany., Granold M; Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany., Petschulies M; Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany., Wu L; Takeda Development Center Americas, Inc. (TDCA), Lexington, USA., Chung YC; Takeda Development Center Americas, Inc. (TDCA), Lexington, USA., Chen L; Takeda Development Center Americas, Inc. (TDCA), Lexington, USA., Yang Z; HUTCHMED International Inc., Florham Park, USA., Van Cutsem E; Gastroenterology/Digestive Oncology, University Hospitals Gasthuisberg/Leuven & KULeuven, Leuven, Belgium.
Source: ESMO open [ESMO Open] 2025 Mar; Vol. 10 (3), pp. 104297. Date of Electronic Publication: 2025 Feb 21.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39985889
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stintzing+S%22">Stintzing S</searchLink>; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology (CCM), Berlin, Germany. Electronic address: sebastian.stintzing@charite.de.<br /><searchLink fieldCode="AU" term="%22Tabernero+J%22">Tabernero J</searchLink>; Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Centro Cellex, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Satoh+T%22">Satoh T</searchLink>; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Dasari+A%22">Dasari A</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Lonardi+S%22">Lonardi S</searchLink>; Medical Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.<br /><searchLink fieldCode="AU" term="%22Eng+C%22">Eng C</searchLink>; Department of Medicine, Vanderbilt Ingram Cancer Center, Nashville, USA.<br /><searchLink fieldCode="AU" term="%22Garcia-Carbonero+R%22">Garcia-Carbonero R</searchLink>; Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Elez+E%22">Elez E</searchLink>; Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Centro Cellex, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Yoshino+T%22">Yoshino T</searchLink>; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Sobrero+AF%22">Sobrero AF</searchLink>; Department of Medical Oncology, Azienda Ospedaliera San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Yao+JC%22">Yao JC</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Kasper+S%22">Kasper S</searchLink>; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Arnold+D%22">Arnold D</searchLink>; Department of Oncology and Hematology, Asklepios Tumorzentrum Hamburg, AK Altona, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Basic+E%22">Basic E</searchLink>; Department of Business and Economics, Berlin School of Economics and Law, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Granold+M%22">Granold M</searchLink>; Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Petschulies+M%22">Petschulies M</searchLink>; Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Wu+L%22">Wu L</searchLink>; Takeda Development Center Americas, Inc. (TDCA), Lexington, USA.<br /><searchLink fieldCode="AU" term="%22Chung+YC%22">Chung YC</searchLink>; Takeda Development Center Americas, Inc. (TDCA), Lexington, USA.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Takeda Development Center Americas, Inc. (TDCA), Lexington, USA.<br /><searchLink fieldCode="AU" term="%22Yang+Z%22">Yang Z</searchLink>; HUTCHMED International Inc., Florham Park, USA.<br /><searchLink fieldCode="AU" term="%22Van+Cutsem+E%22">Van Cutsem E</searchLink>; Gastroenterology/Digestive Oncology, University Hospitals Gasthuisberg/Leuven & KULeuven, Leuven, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2025 Mar; Vol. 10 (3), pp. 104297. <i>Date of Electronic Publication: </i>2025 Feb 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39985889
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.esmoop.2025.104297
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104297
    Titles:
      – TitleFull: Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stintzing S
      – PersonEntity:
          Name:
            NameFull: Tabernero J
      – PersonEntity:
          Name:
            NameFull: Satoh T
      – PersonEntity:
          Name:
            NameFull: Dasari A
      – PersonEntity:
          Name:
            NameFull: Lonardi S
      – PersonEntity:
          Name:
            NameFull: Eng C
      – PersonEntity:
          Name:
            NameFull: Garcia-Carbonero R
      – PersonEntity:
          Name:
            NameFull: Elez E
      – PersonEntity:
          Name:
            NameFull: Yoshino T
      – PersonEntity:
          Name:
            NameFull: Sobrero AF
      – PersonEntity:
          Name:
            NameFull: Yao JC
      – PersonEntity:
          Name:
            NameFull: Kasper S
      – PersonEntity:
          Name:
            NameFull: Arnold D
      – PersonEntity:
          Name:
            NameFull: Basic E
      – PersonEntity:
          Name:
            NameFull: Granold M
      – PersonEntity:
          Name:
            NameFull: Petschulies M
      – PersonEntity:
          Name:
            NameFull: Wu L
      – PersonEntity:
          Name:
            NameFull: Chung YC
      – PersonEntity:
          Name:
            NameFull: Chen L
      – PersonEntity:
          Name:
            NameFull: Yang Z
      – PersonEntity:
          Name:
            NameFull: Van Cutsem E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2025 Mar
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2059-7029
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: ESMO open
              Type: main
ResultId 1